| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8212623 | International Journal of Radiation Oncology*Biology*Physics | 2017 | 27 Pages |
Abstract
Colorectal cancer lung metastases are associated with a higher hazard of LF and require higher SABR doses. Outcomes for patients with oligometastases and oligoprogression treated with SABR seem favorable. Prospective clinical trials are needed to confirm these benefits.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Joelle MD, MSc, Isabelle MD, Ian MD, Andrew MD, Suneil PhD, Hany MD, Darby MRT(T), Latifa MD, MSc, Patrick MD,